This week, the Government launched its 10 Year Health Plan to fix the NHS in England. We take a look at what it means for ...

A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could ...

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...

Ambroxol chaperones GCase; in a previous study of people with Parkinson's disease, the drug led to increased GCase levels. It ...

A 12-month clinical trial investigated whether a cough medicine used in Europe called Ambroxol can slow dementia in people with Parkinson’s.

The research indicated that those with cataracts and systemic conditions were up to 2.29 times more likely to develop ...

Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care London, are investigating ...

A new study involving nearly 1.7 million patients suggests that semaglutide — a drug that mimics a gut hormone to lower blood ...

While memory loss is commonly associated with dementia, research from the University of Chicago suggests that a significant ...

A groundbreaking analysis from leading British universities has uncovered surprising links between everyday medications and ...

Semaglutide has been associated with “slowing dementia development” among people living with type 2 diabetes, new research ...

A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could ...